for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Pacific Biosciences of California Inc

PACB.O

Latest Trade

30.97USD

Change

-3.38(-9.83%)

Volume

4,470,502

Today's Range

30.56

 - 

34.07

52 Week Range

2.20

 - 

53.69

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
34.34
Open
33.49
Volume
4,470,502
3M AVG Volume
111.84
Today's High
34.07
Today's Low
30.56
52 Week High
53.69
52 Week Low
2.20
Shares Out (MIL)
193.10
Market Cap (MIL)
6,631.15
Forward P/E
-35.49
Dividend (Yield %)
--

Next Event

Pacific Biosciences of California Inc at Barclays Global Healthcare Conference (Virtual)

Latest Developments

More

Pacific Biosciences Of California Announces Q4 2020 Financial Results

Pacific Biosciences Announces $900 Mln Investment From SoftBank

Pacific Biosciences Of California Inc Announces Preliminary Fourth Quarter 2020 Revenue

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Pacific Biosciences of California Inc

Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The Company is engaged in the development, manufacturing and marketing of an integrated platform for genetic analysis. Its Single Molecule, Real-Time (SMRT) technology enables single molecule, real-time detection of biological processes. It offers The SMRT Cell, Phospholinked nucleotides and The PacBio RS II and Sequel instruments. Its SMRT technology enables the observation of deoxyribonucleic acid (DNA) synthesis as it occurs in real-time by harnessing the natural process of DNA replication, which is actuated by the DNA polymerase. Its phospholinked nucleotides have a fluorescent dye attached to the phosphate chain of the nucleotide rather than to the base. The PacBio RS II and Sequel instruments include optics, automated liquid handling, a touchscreen control interface and computational hardware and software.

Industry

Medical Equipment & Supplies

Contact Info

1305 O'brien Drive

MENLO PARK, CA

94025

United States

+1.650.5218000

https://www.pacb.com/

Executive Leadership

John F. Milligan

Independent Chairman of the Board

Christian O. Henry

President, Chief Executive Officer, Director

Susan G Kim

Chief Principal Officer, Chief Accounting Officer

Mark Van Oene

Chief Operating Officer

Eric Schaefer

Chief Accounting Officer, Vice President

Key Stats

2.40 mean rating - 5 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

0.1K

2019

0.1K

2020

0.1K

2021(E)

0.1K
EPS (USD)

2018

-0.760

2019

-0.550

2020

0.170

2021(E)

-0.968
Price To Earnings (TTM)
702.39
Price To Sales (TTM)
84.05
Price To Book (MRQ)
19.68
Price To Cash Flow (TTM)
185.07
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
12.40
Return on Equity (TTM)
10.46

Latest News

Latest News

Jury deals loss to PacBio in genetic testing patent fight with Oxford Nanopore

A jury on Wednesday dealt a loss to gene sequencing company Pacific Biosciences of California Inc (PacBio) in its patent infringement case against rival Oxford Nanopore Technologies Ltd.

BRIEF-Pacific Biosciences Posts Favorable Outcome In UK And German Patent Litigation Against Oxford Nanopore

* PACIFIC BIOSCIENCES ANNOUNCES FAVORABLE OUTCOME IN UK AND GERMAN PATENT LITIGATION AGAINST OXFORD NANOPORE

BRIEF-Pacific Biosciences Of California Reports Qtrly Loss Per Share Of $0.20

* PACIFIC BIOSCIENCES OF CALIFORNIA, INC. ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-Pacific Biosciences Announces Ten-Unit Sequel System Order For Annoroad

* PACIFIC BIOSCIENCES ANNOUNCES TEN-UNIT SEQUEL SYSTEM ORDER FOR ANNOROAD Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

BRIEF-Pacific Biosciences Prevails In Patent Eligibility Ruling

* PACIFIC BIOSCIENCES PREVAILS IN PATENT ELIGIBILITY RULING AGAINST OXFORD NANOPORE

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up